Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low‐to‐middle income Asian country

28 Apr 2022

Abstract excerpt

With the advent of poly-ADP-ribose polymerase inhibitor (PARPi) therapies, the focus of genetic testing for breast, ovarian, and other cancers has shifted from risk management to treatment decision-making in high-resource settings. Due to the shortage of genetic counselors worldwide, alternative ways of delivering genetic counseling have been explored, including training nongenetics healthcare professionals...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to PARP inhibition in cancer therapy
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35481858
DOI: 10.1002/jgc4.1579

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low‐to‐middle income Asian countryPMID 35481858Read ↗

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomesSemantic proximity Read ↗

Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in AsiaSemantic proximity Read ↗

Knowledge, Attitude and Perceptions about Cancer Genetic Testing in Clinical Practice in Karachi, PakistanSemantic proximity Read ↗

Knowledge and perceptions of genetic testing for patients with breast cancer in Nigeria: a survey of healthcare providersSemantic proximity Read ↗

Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients.Semantic proximity Read ↗

Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1/2 mutation Carriers’ experience with genetic testing and counselingSemantic proximity Read ↗

Breast cancer specialists’ experiences and attitudes towards mainstream genetic testing for patients with breast cancerSemantic proximity Read ↗

Obstacles in genetic testing for germline BRCA1/2 pathogenic mutations in patients with primary breast and ovarian cancer in Switzerland.Semantic proximity Read ↗

Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico.Semantic proximity Read ↗

Genetic counseling for breast cancer risk: how did we get here and where are we going?Semantic proximity Read ↗

Factors shaping at-risk individuals' decisions to undergo genetic testing for cancer in Asia.Semantic proximity Read ↗

A profile of genetic counseling and testing in Chinese patients with gynecologic oncology: a nationwide survey of Chinese gynecologistsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.